S159 Efficacy and Safety of RBX2660 in Reducing Recurrent Clostridioides difficile Infection in Patients With Underlying Gastrointestinal Comorbidities. (October 2022) - Dubberke, Erik R.; Knapple, Whitfield L.; Feuerstadt, Paul; Assi, Maha; Ng, Samson; Guthmueller, Beth; Ando, Masakazu